The Leaf Index
Vol. IA field guide to cannabis cultivarsleafly.cc
No. 7490Indica

Tangerine G13 by Amsterdam Genetics

G13 × Citrus Strain

Tangerine G13 is an indica-dominant hybrid developed by Amsterdam Genetics, combining the potent legacy of G13 with a vibrant tangerine aroma and flavor. This strain is recognized for its balanced genetic profile and distinct sensory characteristics.

EffectsCalm
May help withPain Stress
AromaCitrusEarthyHerbalPepperySpicy

Appearance

Tangerine G13 presents visually striking, dense buds characteristic of its indica heritage. These nugs are often adorned with a rich coating of trichomes, giving them a crystalline appearance. Subtle tangerine hues and occasional hints of purple can be observed along the edges of the compact buds, with growers noting that the leaves may sometimes exhibit a citrus tint.

The resin production is substantial, contributing to both the strain's visual appeal and its potential therapeutic qualities. The buds can grow to a considerable size, reflecting the robust nature of its indica lineage and making it a favored choice for both aesthetic and practical cultivation.

Aroma & Flavor

The aroma of Tangerine G13 is a complex fusion of earthy and citrus notes, with the dominant terpene, myrcene, providing a rich, musky base. This is complemented by the sharp, refreshing scent of limonene, which introduces distinct citrus qualities. Caryophyllene adds a layer of spicy and peppery fragrance, creating a multifaceted olfactory experience.

Consumers experience a pronounced tangerine flavor upon inhalation, which evolves into a more complex profile as consumption progresses. The initial burst of citrus is grounded by the earthy undertones derived from myrcene, while caryophyllene contributes a subtle spiciness. This interplay of sweet citrus, earthy depth, and spicy nuances creates a dynamic and memorable flavor journey.

Effects

Tangerine G13 is primarily known for delivering a commanding physical experience, consistent with its indica dominance. Users report a sense of calm and relaxation, often described as a potent body high that can be both grounding and soothing.

The strain's effects are generally considered to be sedating, making it a suitable choice for unwinding. While not explicitly detailed in the source, the calming properties suggest potential applications for managing everyday stress and discomfort.

Terpenes & Cannabinoids

The terpene profile of Tangerine G13 is characterized by a dominant presence of myrcene, often found in significant percentages within G13 strains, which contributes to its earthy aroma and potential relaxing effects. Limonene adds a bright citrus note, while caryophyllene introduces spicy and peppery undertones.

This strain typically exhibits THC levels ranging from 18-22%, with CBD content below 1%. The genetic makeup ensures a strong indica influence, contributing to its characteristic cannabinoid profile and potency.

Origins & Lineage

Tangerine G13 was meticulously bred by Amsterdam Genetics, a company known for its focus on genetic stability and consistent phenotypic expression. The strain is a hybrid that crosses the legendary G13 with a citrus-forward variety, aiming to enhance the potent indica traits of G13 with a distinctive tangerine flavor profile.

This careful hybridization process, supported by modern genetic tools, has resulted in a stable indica-dominant strain. The lineage is a testament to Amsterdam Genetics' commitment to innovative breeding, creating a unique cultivar that honors its potent ancestry while offering a fresh sensory experience.

Frequently asked questions

What is the THC content of Tangerine G13?
Tangerine G13 typically has a THC content ranging from 18-22%.
What are the dominant terpenes in Tangerine G13?
The dominant terpenes in Tangerine G13 are Myrcene, Limonene, and Caryophyllene, contributing to its earthy, citrus, and spicy aroma and flavor.
What type of strain is Tangerine G13?
Tangerine G13 is an indica-dominant hybrid strain.
Who developed the Tangerine G13 strain?
Tangerine G13 was developed by Amsterdam Genetics.